Changes / RenewalRSSAbout RSS
- July 30, 2018 Information " Financial Results " was updated.
- July 23, 2018 Information " Annual Report " was updated.
- June 28, 2018 Release JT and Torii Discontinue Development of NK-1 Receptor Antagonist (JTS-661) and Terminate Exclusive License Agreement with Menlo Therapeutics（PDF）
- May 24, 2018 Release Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar Pollinosis（PDF）
- April 26, 2018 Information " Financial Results " was updated.